Century Therapeutics, Inc. (IPSC) Misses Q2 EPS by 6c

Century Therapeutics, Inc. (NASDAQ: IPSC) reported Q2 EPS of ($0.17), $0.06 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Century Therapeutics, Inc. (IPSC) click here.

You May Also Be Interested In

• GameStop CEO Cohen buys 1.15M shares
• Oxford Nanopore (ONT:LN) (ONTTF) PT Raised to GBP2.10 at Deutsche Bank
• Innovent Biologics Inc. (1801:HK) (IVBXF) PT Raised to HK$128 at Bernstein SocGen Group